{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:26:22Z","timestamp":1790681182718,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16K15386"],"award-info":[{"award-number":["16K15386"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00204-021-03195-w","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:03:16Z","timestamp":1641772996000},"page":"545-558","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["SUMOylation regulates the number and size of promyelocytic leukemia-nuclear bodies (PML-NBs) and arsenic perturbs SUMO dynamics on PML by insolubilizing PML in THP-1 cells"],"prefix":"10.1007","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4148-0624","authenticated-orcid":false,"given":"Seishiro","family":"Hirano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Udagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"issue":"5794","key":"3195_CR1","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1126\/science.1128406","volume":"313","author":"F Alkuraya","year":"2006","unstructured":"Alkuraya F, Saadi I, Lund J, Turbe-Doan A, Morton C, Maas R (2006) SUMO1 haploinsufficiency leads to cleft lip and palate. Science 313(5794):1751. https:\/\/doi.org\/10.1126\/science.1128406","journal-title":"Science"},{"issue":"9","key":"3195_CR2","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1182\/blood-2008-06-161000","volume":"112","author":"W Au","year":"2008","unstructured":"Au W, Tam S, Fong B, Kwong Y (2008) Determinants of cerebrospinal fluid arsenic concentration in patients with acute promyelocytic leukemia on oral arsenic trioxide therapy. Blood 112(9):3587\u20133590. https:\/\/doi.org\/10.1182\/blood-2008-06-161000","journal-title":"Blood"},{"issue":"5","key":"3195_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178056","volume":"12","author":"D Baczyk","year":"2017","unstructured":"Baczyk D, Audette M, Drewlo S, Levytska K, Kingdom J (2017) SUMO-4: a novel functional candidate in the human placental protein SUMOylation machinery. PLoS\u00a0One 12(5):e0178056. https:\/\/doi.org\/10.1371\/journal.pone.0178056","journal-title":"PLoS\u00a0One"},{"issue":"4","key":"3195_CR4","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1073\/pnas.93.4.1601","volume":"93","author":"K Borden","year":"1996","unstructured":"Borden K, Lally J, Martin S, O\u2019Reilly N, Solomon E, Freemont P (1996) In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML. Proc Natl Acad Sci USA 93(4):1601\u20131606. https:\/\/doi.org\/10.1073\/pnas.93.4.1601","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"3195_CR5","doi-asserted-by":"publisher","first-page":"438","DOI":"10.21037\/atm.2016.08.53","volume":"4","author":"H Bosshart","year":"2016","unstructured":"Bosshart H, Heinzelmann M (2016) THP-1 cells as a model for human monocytes. Ann Transl Med 4(21):438. https:\/\/doi.org\/10.21037\/atm.2016.08.53","journal-title":"Ann Transl Med"},{"key":"3195_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fonc.2012.00026","volume":"2","author":"J Cao","year":"2012","unstructured":"Cao J, Yan Q (2012) Histone ubiquitination and deubiquitination in transcription, DNA damage response, and cancer. Front Oncol 2:26. https:\/\/doi.org\/10.3389\/fonc.2012.00026","journal-title":"Front Oncol"},{"issue":"8","key":"3195_CR7","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3390\/molecules23081958","volume":"23","author":"K Cermakova","year":"2018","unstructured":"Cermakova K, Hodges H (2018) Next-generation drugs and probes for chromatin biology: from targeted protein degradation to phase separation. Molecules 23(8):1958. https:\/\/doi.org\/10.3390\/molecules23081958","journal-title":"Molecules"},{"issue":"1","key":"3195_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1083\/jcb.201112044","volume":"198","author":"H de The","year":"2012","unstructured":"de The H, Le Bras M, Lallemand-Breitenbach V (2012) The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies. J Cell Biol 198(1):11\u201321. https:\/\/doi.org\/10.1083\/jcb.201112044","journal-title":"J Cell Biol"},{"issue":"Pt 24","key":"3195_CR9","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1242\/jcs.038570","volume":"121","author":"E Evdokimov","year":"2008","unstructured":"Evdokimov E, Sharma P, Lockett S, Lualdi M, Kuehn M (2008) Loss of SUMO1 in mice affects RanGAP1 localization and formation of PML nuclear bodies, but is not lethal as it can be compensated by SUMO2 or SUMO3. J Cell Sci 121(Pt 24):4106\u20134113. https:\/\/doi.org\/10.1242\/jcs.038570","journal-title":"J Cell Sci"},{"issue":"35","key":"3195_CR10","doi-asserted-by":"publisher","first-page":"5401","DOI":"10.1038\/sj.onc.1208714","volume":"24","author":"C Fu","year":"2005","unstructured":"Fu C, Ahmed K, Ding H et al (2005) Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3. Oncogene 24(35):5401\u20135413. https:\/\/doi.org\/10.1038\/sj.onc.1208714","journal-title":"Oncogene"},{"issue":"1731","key":"3195_CR11","doi-asserted-by":"publisher","first-page":"20160281","DOI":"10.1098\/rstb.2016.0281","volume":"372","author":"A Garvin","year":"2017","unstructured":"Garvin A, Morris J (2017) SUMO, a small, but powerful, regulator of double-strand break repair. Philos Trans R Soc Lond B Biol Sci 372(1731):20160281. https:\/\/doi.org\/10.1098\/rstb.2016.0281","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"72","key":"3195_CR12","doi-asserted-by":"publisher","first-page":"ra24","DOI":"10.1126\/scisignal.2000282","volume":"2","author":"F Golebiowski","year":"2009","unstructured":"Golebiowski F, Matic I, Tatham M et al (2009) System-wide changes to SUMO modifications in response to heat shock. Sci Signal 2(72):ra24. https:\/\/doi.org\/10.1126\/scisignal.2000282","journal-title":"Sci Signal"},{"issue":"4","key":"3195_CR13","doi-asserted-by":"publisher","first-page":"512","DOI":"10.15252\/embr.201440017","volume":"16","author":"R Gonzalez-Prieto","year":"2015","unstructured":"Gonzalez-Prieto R, Cuijpers SA, Luijsterburg MS, van Attikum H, Vertegaal AC (2015) SUMOylation and PARylation cooperate to recruit and stabilize SLX4 at DNA damage sites. EMBO Rep 16(4):512\u2013519. https:\/\/doi.org\/10.15252\/embr.201440017","journal-title":"EMBO Rep"},{"issue":"11","key":"3195_CR14","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/nchembio.2463","volume":"13","author":"X He","year":"2017","unstructured":"He X, Riceberg J, Soucy T et al (2017) Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor. Nat Chem Biol 13(11):1164\u20131171. https:\/\/doi.org\/10.1038\/nchembio.2463","journal-title":"Nat Chem Biol"},{"issue":"9","key":"3195_CR15","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrm.2016.81","volume":"17","author":"IA Hendriks","year":"2016","unstructured":"Hendriks IA, Vertegaal AC (2016) A comprehensive compilation of SUMO proteomics. Nat Rev Mol Cell Biol 17(9):581\u2013595. https:\/\/doi.org\/10.1038\/nrm.2016.81","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"3195_CR16","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/nsmb.2890","volume":"21","author":"IA Hendriks","year":"2014","unstructured":"Hendriks IA, D\u2019Souza RC, Yang B, Verlaan-de Vries M, Mann M, Vertegaal AC (2014) Uncovering global SUMOylation signaling networks in a site-specific manner. Nat Struct Mol Biol 21(10):927\u2013936. https:\/\/doi.org\/10.1038\/nsmb.2890","journal-title":"Nat Struct Mol Biol"},{"issue":"8","key":"3195_CR17","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1007\/s00204-020-02772-9","volume":"94","author":"S Hirano","year":"2020","unstructured":"Hirano S (2020) Biotransformation of arsenic and toxicological implication of arsenic metabolites. Arch Toxicol 94(8):2587\u20132601. https:\/\/doi.org\/10.1007\/s00204-020-02772-9","journal-title":"Arch Toxicol"},{"issue":"3","key":"3195_CR18","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.taap.2013.10.004","volume":"273","author":"S Hirano","year":"2013","unstructured":"Hirano S, Watanabe T, Kobayashi Y (2013) Effects of arsenic on modification of promyelocytic leukemia (PML): PML responds to low levels of arsenite. Toxicol Appl Pharmacol 273(3):590\u2013599. https:\/\/doi.org\/10.1016\/j.taap.2013.10.004","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"3195_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.taap.2015.05.018","volume":"287","author":"S Hirano","year":"2015","unstructured":"Hirano S, Tadano M, Kobayashi Y, Udagawa O, Kato A (2015) Solubility shift and SUMOylaltion of promyelocytic leukemia (PML) protein in response to arsenic(III) and fate of the SUMOylated PML. Toxicol Appl Pharmacol 287(3):191\u2013201. https:\/\/doi.org\/10.1016\/j.taap.2015.05.018","journal-title":"Toxicol Appl Pharmacol"},{"key":"3195_CR20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.taap.2018.10.001","volume":"360","author":"S Hirano","year":"2018","unstructured":"Hirano S, Udagawa O, Kobayashi Y, Kato A (2018) Solubility changes of promyelocytic leukemia (PML) and SUMO monomers and dynamics of PML nuclear body proteins in arsenite-treated cells. Toxicol Appl Pharmacol 360:150\u2013159. https:\/\/doi.org\/10.1016\/j.taap.2018.10.001","journal-title":"Toxicol Appl Pharmacol"},{"key":"3195_CR21","volume-title":"Arsenic and arsenic compounds","author":"IPCS","year":"2001","unstructured":"IPCS (2001) Arsenic and arsenic compounds, vol 224. World Health Organization, Geneva"},{"issue":"2","key":"3195_CR22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1083\/jcb.147.2.221","volume":"147","author":"AM Ishov","year":"1999","unstructured":"Ishov AM, Sotnikov AG, Negorev D et al (1999) PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol 147(2):221\u2013234","journal-title":"J Cell Biol"},{"issue":"42","key":"3195_CR23","doi-asserted-by":"publisher","first-page":"15235","DOI":"10.1074\/jbc.H119.011037","volume":"294","author":"J Jin","year":"2019","unstructured":"Jin J (2019) Interplay between ubiquitylation and SUMOylation: empowered by phase separation. J Biol Chem 294(42):15235\u201315236. https:\/\/doi.org\/10.1074\/jbc.H119.011037","journal-title":"J Biol Chem"},{"issue":"12","key":"3195_CR24","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1084\/jem.193.12.1361","volume":"193","author":"V Lallemand-Breitenbach","year":"2001","unstructured":"Lallemand-Breitenbach V, Zhu J, Puvion F et al (2001) Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML\/retinoic acid receptor alpha degradation. J Exp Med 193(12):1361\u20131371","journal-title":"J Exp Med"},{"issue":"5","key":"3195_CR25","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/ncb1717","volume":"10","author":"V Lallemand-Breitenbach","year":"2008","unstructured":"Lallemand-Breitenbach V, Jeanne M, Benhenda S et al (2008) Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4\/ubiquitin-mediated pathway. Nat Cell Biol 10(5):547\u2013555. https:\/\/doi.org\/10.1038\/ncb1717","journal-title":"Nat Cell Biol"},{"issue":"1","key":"3195_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.molmed.2011.10.001","volume":"18","author":"V Lallemand-Breitenbach","year":"2012","unstructured":"Lallemand-Breitenbach V, Zhu J, Chen Z, de The H (2012) Curing APL through PML\/RARA degradation by As2O3. Trends Mol Med 18(1):36\u201342. https:\/\/doi.org\/10.1016\/j.molmed.2011.10.001","journal-title":"Trends Mol Med"},{"key":"3195_CR27","doi-asserted-by":"publisher","first-page":"14109","DOI":"10.1038\/ncomms14109","volume":"8","author":"F Lamoliatte","year":"2017","unstructured":"Lamoliatte F, McManus FP, Maarifi G, Chelbi-Alix MK, Thibault P (2017) Uncovering the SUMOylation and ubiquitylation crosstalk in human cells using sequential peptide immunopurification. Nat Commun 8:14109. https:\/\/doi.org\/10.1038\/ncomms14109","journal-title":"Nat Commun"},{"issue":"8","key":"3195_CR28","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3390\/cells8080893","volume":"8","author":"A Lang","year":"2019","unstructured":"Lang A, Lang E, Boe S (2019) PML bodies in mitosis. Cells 8(8):893. https:\/\/doi.org\/10.3390\/cells8080893","journal-title":"Cells"},{"key":"3195_CR29","doi-asserted-by":"publisher","first-page":"26509","DOI":"10.1038\/srep26509","volume":"6","author":"YC Liang","year":"2016","unstructured":"Liang YC, Lee CC, Yao YL, Lai CC, Schmitz ML, Yang WM (2016) SUMO5, a novel poly-SUMO isoform. Regulates PML Nuclear Bodies Sci Rep 6:26509. https:\/\/doi.org\/10.1038\/srep26509","journal-title":"Regulates PML Nuclear Bodies Sci Rep"},{"issue":"4","key":"3195_CR30","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1158\/2643-3230.BCD-20-0188","volume":"2","author":"Y Maimaitiyiming","year":"2021","unstructured":"Maimaitiyiming Y, Wang Q, Yang C et al (2021) Hyperthermia selectively destabilizes oncogenic fusion proteins. Blood Cancer Discov 2(4):388\u2013401. https:\/\/doi.org\/10.1158\/2643-3230.BCD-20-0188","journal-title":"Blood Cancer Discov"},{"issue":"9","key":"3195_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044949","volume":"7","author":"M Maroui","year":"2012","unstructured":"Maroui M, Kheddache-Atmane S, El AF, Dianoux L, Aubry M, Chelbi-Alix M (2012) Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms. PLoS\u00a0One 7(9):e44949. https:\/\/doi.org\/10.1371\/journal.pone.0044949","journal-title":"PLoS\u00a0One"},{"issue":"6","key":"3195_CR32","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.devcel.2005.10.007","volume":"9","author":"K Nacerddine","year":"2005","unstructured":"Nacerddine K, Lehembre F, Bhaumik M et al (2005) The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Dev Cell 9(6):769\u2013779. https:\/\/doi.org\/10.1016\/j.devcel.2005.10.007","journal-title":"Dev Cell"},{"key":"3195_CR33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3389\/fonc.2013.00125","volume":"3","author":"S Nisole","year":"2013","unstructured":"Nisole S, Maroui M, Mascle X, Aubry M, Chelbi-Alix M (2013) Differential Roles of PML Isoforms. Front Oncol 3:125. https:\/\/doi.org\/10.3389\/fonc.2013.00125","journal-title":"Front Oncol"},{"issue":"2","key":"3195_CR34","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.bbrc.2005.09.090","volume":"337","author":"D Owerbach","year":"2005","unstructured":"Owerbach D, McKay E, Yeh E, Gabbay K, Bohren K (2005) A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation. Biochem Biophys Res Commun 337(2):517\u2013520. https:\/\/doi.org\/10.1016\/j.bbrc.2005.09.090","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"3195_CR35","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/nsmb1168","volume":"13","author":"D Reverter","year":"2006","unstructured":"Reverter D, Lima C (2006) Structural basis for SENP2 protease interactions with SUMO precursors and conjugated substrates. Nat Struct Mol Biol 13(12):1060\u20131068. https:\/\/doi.org\/10.1038\/nsmb1168","journal-title":"Nat Struct Mol Biol"},{"issue":"49","key":"3195_CR36","doi-asserted-by":"publisher","first-page":"7243","DOI":"10.1038\/sj.onc.1204758","volume":"20","author":"J Seeler","year":"2001","unstructured":"Seeler J, Dejean A (2001) SUMO: of branched proteins and nuclear bodies. Oncogene 20(49):7243\u20137249. https:\/\/doi.org\/10.1038\/sj.onc.1204758","journal-title":"Oncogene"},{"key":"3195_CR37","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA119.009147","author":"Z Sha","year":"2019","unstructured":"Sha Z, Blyszcz T, Gonzalez-Prieto R, Vertegaal A, Goldberg A (2019) Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.RA119.009147","journal-title":"J Biol Chem"},{"issue":"15","key":"3195_CR38","doi-asserted-by":"publisher","first-page":"5328","DOI":"10.1073\/pnas.0400053101","volume":"101","author":"Z Shen","year":"2004","unstructured":"Shen Z, Shi Z, Fang J et al (2004) All-trans retinoic acid\/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci USA 101(15):5328\u20135335. https:\/\/doi.org\/10.1073\/pnas.0400053101","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"3195_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193601","volume":"13","author":"T Starr","year":"2018","unstructured":"Starr T, Bauler T, Malik-Kale P, Steele-Mortimer O (2018) The phorbol 12-myristate-13-acetate differentiation protocol is critical to the interaction of THP-1 macrophages with Salmonella Typhimurium. PLoS\u00a0One 13(3):e0193601. https:\/\/doi.org\/10.1371\/journal.pone.0193601","journal-title":"PLoS\u00a0One"},{"issue":"1","key":"3195_CR40","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1158\/2643-3230.bcd-19-0028","volume":"1","author":"A Stoddart","year":"2020","unstructured":"Stoddart A, Wang J, Fernald A et al (2020) Cytotoxic therapy-induced effects on both hematopoietic and marrow stromal cells promotes therapy-related myeloid neoplasms. Blood Cancer Discov 1(1):32. https:\/\/doi.org\/10.1158\/2643-3230.bcd-19-0028","journal-title":"Blood Cancer Discov"},{"issue":"1\u20132","key":"3195_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/s0378-1119(02)00843-0","volume":"296","author":"H Su","year":"2002","unstructured":"Su H, Li S (2002) Molecular features of human ubiquitin-like SUMO genes and their encoded proteins. Gene 296(1\u20132):65\u201373. https:\/\/doi.org\/10.1016\/s0378-1119(02)00843-0","journal-title":"Gene"},{"issue":"12","key":"3195_CR42","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.4049\/jimmunol.145.12.4338","volume":"145","author":"C Szostecki","year":"1990","unstructured":"Szostecki C, Guldner H, Netter H, Will H (1990) Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J Immunol 145(12):4338\u20134347","journal-title":"J Immunol"},{"issue":"5","key":"3195_CR43","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/ncb1716","volume":"10","author":"MH Tatham","year":"2008","unstructured":"Tatham MH, Geoffroy MC, Shen L et al (2008) RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat Cell Biol 10(5):538\u2013546. https:\/\/doi.org\/10.1038\/ncb1716","journal-title":"Nat Cell Biol"},{"issue":"1","key":"3195_CR44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.scr.2014.05.002","volume":"13","author":"L Vossaert","year":"2014","unstructured":"Vossaert L, Meert P, Scheerlinck E et al (2014) Identification of histone H3 clipping activity in human embryonic stem cells. Stem Cell Res 13(1):123\u2013134. https:\/\/doi.org\/10.1016\/j.scr.2014.05.002","journal-title":"Stem Cell Res"},{"issue":"8","key":"3195_CR45","doi-asserted-by":"publisher","first-page":"878","DOI":"10.15252\/embr.201438534","volume":"15","author":"L Wang","year":"2014","unstructured":"Wang L, Wansleeben C, Zhao S, Miao P, Paschen W, Yang W (2014) SUMO2 is essential while SUMO3 is dispensable for mouse embryonic development. EMBO Rep 15(8):878\u2013885. https:\/\/doi.org\/10.15252\/embr.201438534","journal-title":"EMBO Rep"},{"issue":"1","key":"3195_CR46","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41467-018-03498-0","volume":"9","author":"P Wang","year":"2018","unstructured":"Wang P, Benhenda S, Wu H et al (2018) RING tetramerization is required for nuclear body biogenesis and PML sumoylation. Nat Commun 9(1):1277. https:\/\/doi.org\/10.1038\/s41467-018-03498-0","journal-title":"Nat Commun"},{"key":"3195_CR47","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.18413","author":"J Wheeler","year":"2016","unstructured":"Wheeler J, Matheny T, Jain S, Abrisch R, Parker R (2016) Distinct stages in stress granule assembly and disassembly. Elife. https:\/\/doi.org\/10.7554\/eLife.18413","journal-title":"Elife"},{"key":"3195_CR48","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1158\/2643-3230.BCD-21-0071","volume":"2","author":"H Wu","year":"2021","unstructured":"Wu H, Rerolle D, de The H (2021) PML\/RARA destabilization by hyperthermia: a new model for oncogenic fusion protein degradation? Blood Cancer Discov 2:300\u2013301. https:\/\/doi.org\/10.1158\/2643-3230.BCD-21-0071","journal-title":"Blood Cancer Discov"},{"issue":"17","key":"3195_CR49","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1128\/MCB.00651-08","volume":"28","author":"F Zhang","year":"2008","unstructured":"Zhang F, Mikkonen L, Toppari J, Palvimo J, Thesleff I, Janne O (2008) Sumo-1 function is dispensable in normal mouse development. Mol Cell Biol 28(17):5381\u20135390. https:\/\/doi.org\/10.1128\/MCB.00651-08","journal-title":"Mol Cell Biol"},{"issue":"9","key":"3195_CR50","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1182\/blood.V95.9.2748.009k31a_2748_2752","volume":"95","author":"S Zhong","year":"2000","unstructured":"Zhong S, Muller S, Ronchetti S, Freemont P, Dejean A, Pandolfi P (2000) Role of SUMO-1-modified PML in nuclear body formation. Blood 95(9):2748\u20132752","journal-title":"Blood"},{"issue":"5","key":"3195_CR51","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.molcel.2009.02.008","volume":"33","author":"S Zhu","year":"2009","unstructured":"Zhu S, Goeres J, Sixt K et al (2009) Protection from isopeptidase-mediated deconjugation regulates paralog-selective sumoylation of RanGAP1. Mol Cell 33(5):570\u2013580. https:\/\/doi.org\/10.1016\/j.molcel.2009.02.008","journal-title":"Mol Cell"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-021-03195-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-021-03195-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-021-03195-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,22]],"date-time":"2023-01-22T10:12:55Z","timestamp":1674382375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-021-03195-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["3195"],"URL":"https:\/\/doi.org\/10.1007\/s00204-021-03195-w","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,10]]},"assertion":[{"value":"2 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest regarding the contents of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}